HYPRNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Hyperfine, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$0.78+0.02 (+2.97%)
Close on Oct 19, 2026
- Market cap
- $77.56M
- P/E (TTM)
- –
- Dividend yield
- –
Hyperfine, Inc. revenue by segment
By business segment
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Device | $14.18M | $13.13M | $11.40M | $8.28M | $8.43M | $9.27M | $10.45M | $10.78M | $9.48M | $9.32M | $8.75M | $7.61M | 85.7% | +68.2% |
| Service | $2.36M | $2.20M | $2.17M | $2.31M | $2.37M | $2.46M | $2.44M | $2.47M | $2.46M | $2.37M | $2.29M | $2.16M | 14.3% | -0.4% |
By region
From the segment and revenue-disaggregation notes of Hyperfine's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.